FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068653181> ?p ?o ?g. }

• W2068653181 endingPage "320" @default.
• W2068653181 startingPage "316" @default.
• W2068653181 abstract "Background. Teriparatide is a recombinant human parathormone (PTH 1–34) currently approved for the treatment of osteoporosis with high risk of fracture. In this study, we analyze the efficacy and safety profile of teriparatide therapy in severe and prolonged hypocalcemia after kidney transplantation in patients previously submitted to parathyroidectomy. Methods. The authors report results from a series of five hemodialyzed patients (mean age: 50±15 years; three female) previously submitted to parathyroidectomy to control secondary hyperparathyroidism. All patients had developed severe refractory hypocalcemia (calcium minimum levels: 5±1.4 mg/dL) early after kidney transplantation. The effect of teriparatide in calcemia and phosphatemia levels was analyzed, and variations in calcium and vitamin D analog requirements were analyzed. Secondary effects and serum creatinine changes were also ascertained. Results. Teriparatide therapy was initiated 32±14 days after the development of hypocalcemia. As a result, calcemia levels increased (median±standard deviation [SD]: 6.7±0.8 vs. 8.5±0.8 mg/dL, P=0.024) allowing suspension of intravenous calcium in two patients and reduction of calcitriol doses (mean±SD: 1.1±0.38 vs. 0.55±0.27 μg/day, P=0.004). In addition, phosphatemia levels (median±SD: 5.1±1.5 vs. 3.9±0.5 mg/dL, P=0.09) and calcium carbonate requirements (mean±SD: 13.8±9.4 vs. 7.2 ±3.7 g/day, P=0.9) exhibited declining trends. No secondary effects were observed and creatinemia remained stable. Conclusions. Our data strongly suggest that refractory hypocalcemia after kidney transplantation in patients with low PTH levels can be successfully treated with teriparatide. PTH analog therapy leads to faster normalization of calcemia, permits earlier suspension of intravenous calcium supplementation, and reduces calcitriol requirements." @default.
• W2068653181 created "2016-06-24" @default.
• W2068653181 creator A5007013175 @default.
• W2068653181 creator A5042773280 @default.
• W2068653181 creator A5055990469 @default.
• W2068653181 creator A5066923371 @default.
• W2068653181 creator A5072692601 @default.
• W2068653181 creator A5077847108 @default.
• W2068653181 creator A5078172515 @default.
• W2068653181 date "2011-08-15" @default.
• W2068653181 modified "2023-10-18" @default.
• W2068653181 title "Teriparatide Efficacy in the Treatment of Severe Hypocalcemia After Kidney Transplantation in Parathyroidectomized Patients: A Series of Five Case Reports" @default.
• W2068653181 cites W1967066959 @default.
• W2068653181 cites W1971000263 @default.
• W2068653181 cites W2002917678 @default.
• W2068653181 cites W2004195185 @default.
• W2068653181 cites W2016819815 @default.
• W2068653181 cites W2042007405 @default.
• W2068653181 cites W2049437029 @default.
• W2068653181 cites W2069729101 @default.
• W2068653181 cites W2072220728 @default.
• W2068653181 cites W2081432593 @default.
• W2068653181 cites W2096371744 @default.
• W2068653181 cites W2102852956 @default.
• W2068653181 cites W2139133651 @default.
• W2068653181 cites W2140043187 @default.
• W2068653181 cites W2163594155 @default.
• W2068653181 cites W2325858960 @default.
• W2068653181 cites W1968802672 @default.
• W2068653181 doi "https://doi.org/10.1097/tp.0b013e3182247b98" @default.
• W2068653181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21694663" @default.
• W2068653181 hasPublicationYear "2011" @default.
• W2068653181 type Work @default.
• W2068653181 sameAs 2068653181 @default.
• W2068653181 citedByCount "24" @default.
• W2068653181 countsByYear W20686531812012 @default.
• W2068653181 countsByYear W20686531812013 @default.
• W2068653181 countsByYear W20686531812014 @default.
• W2068653181 countsByYear W20686531812015 @default.
• W2068653181 countsByYear W20686531812017 @default.
• W2068653181 countsByYear W20686531812018 @default.
• W2068653181 countsByYear W20686531812019 @default.
• W2068653181 countsByYear W20686531812020 @default.
• W2068653181 countsByYear W20686531812023 @default.
• W2068653181 crossrefType "journal-article" @default.
• W2068653181 hasAuthorship W2068653181A5007013175 @default.
• W2068653181 hasAuthorship W2068653181A5042773280 @default.
• W2068653181 hasAuthorship W2068653181A5055990469 @default.
• W2068653181 hasAuthorship W2068653181A5066923371 @default.
• W2068653181 hasAuthorship W2068653181A5072692601 @default.
• W2068653181 hasAuthorship W2068653181A5077847108 @default.
• W2068653181 hasAuthorship W2068653181A5078172515 @default.
• W2068653181 hasBestOaLocation W20686531811 @default.
• W2068653181 hasConcept C121332964 @default.
• W2068653181 hasConcept C124490489 @default.
• W2068653181 hasConcept C126322002 @default.
• W2068653181 hasConcept C126894567 @default.
• W2068653181 hasConcept C134018914 @default.
• W2068653181 hasConcept C141071460 @default.
• W2068653181 hasConcept C142424586 @default.
• W2068653181 hasConcept C2775945674 @default.
• W2068653181 hasConcept C2776079296 @default.
• W2068653181 hasConcept C2776541429 @default.
• W2068653181 hasConcept C2777308945 @default.
• W2068653181 hasConcept C2777645128 @default.
• W2068653181 hasConcept C2778838027 @default.
• W2068653181 hasConcept C2780303639 @default.
• W2068653181 hasConcept C2780306776 @default.
• W2068653181 hasConcept C2781208988 @default.
• W2068653181 hasConcept C2911091166 @default.
• W2068653181 hasConcept C519063684 @default.
• W2068653181 hasConcept C71924100 @default.
• W2068653181 hasConcept C87355193 @default.
• W2068653181 hasConcept C90924648 @default.
• W2068653181 hasConceptScore W2068653181C121332964 @default.
• W2068653181 hasConceptScore W2068653181C124490489 @default.
• W2068653181 hasConceptScore W2068653181C126322002 @default.
• W2068653181 hasConceptScore W2068653181C126894567 @default.
• W2068653181 hasConceptScore W2068653181C134018914 @default.
• W2068653181 hasConceptScore W2068653181C141071460 @default.
• W2068653181 hasConceptScore W2068653181C142424586 @default.
• W2068653181 hasConceptScore W2068653181C2775945674 @default.
• W2068653181 hasConceptScore W2068653181C2776079296 @default.
• W2068653181 hasConceptScore W2068653181C2776541429 @default.
• W2068653181 hasConceptScore W2068653181C2777308945 @default.
• W2068653181 hasConceptScore W2068653181C2777645128 @default.
• W2068653181 hasConceptScore W2068653181C2778838027 @default.
• W2068653181 hasConceptScore W2068653181C2780303639 @default.
• W2068653181 hasConceptScore W2068653181C2780306776 @default.
• W2068653181 hasConceptScore W2068653181C2781208988 @default.
• W2068653181 hasConceptScore W2068653181C2911091166 @default.
• W2068653181 hasConceptScore W2068653181C519063684 @default.
• W2068653181 hasConceptScore W2068653181C71924100 @default.
• W2068653181 hasConceptScore W2068653181C87355193 @default.
• W2068653181 hasConceptScore W2068653181C90924648 @default.
• W2068653181 hasIssue "3" @default.
• W2068653181 hasLocation W20686531811 @default.
• W2068653181 hasLocation W20686531812 @default.

• next